| Literature DB >> 31756458 |
Junyan Yan1, Huarong Huang2, Zuping Liu3, Jiayuan Shen3, Jian Ni1, Jiwei Han3, Renjun Wang4, Derong Lin5, Baowei Hu6, Lifang Jin7.
Abstract
With the spread of hexavalent chromium [Cr(VI)] contamination, risk of exposure in non-occupational populations is increasing. The liver is the main target organ for Cr(VI) accumulation; however, the effect of long-term Cr(VI) exposure on liver toxicity is largely unknown. In this study, we investigated the effect of chronic Cr(VI) exposure on liver fibrosis and its possible mechanism. Mice were injected with Cr(VI) for two months, and our results showed Cr(VI) treatment caused liver toxicity characterized by liver structure disorganization, liver dysfunction, and antioxidant enzyme system inhibition. The development of liver fibrosis was also found via the emergence of collagen fibril deposition, increased expression of extracellular matrix-related genes, activation of hepatic stellate cells (HSCs) and increase the expression levels of Hedgehog (Hh) signaling pathway-related molecules. To demonstrate the role of Hh signaling in the regulation of Cr(VI)-induced liver fibrosis, genetically modified mice with heterozygous deficiency of Shh (Shh+/-) were used. In the Shh+/- mice, Hh signaling, HSCs activation and liver fibrosis development were all ameliorated. In conclusion, we demonstrated that Cr(VI)-induced liver fibrosis development resulted from Hh pathway-mediated HSCs activation. Our findings strongly suggest that inhibition of Hh pathway may help in the development of new strategies for Cr(VI)-associated liver fibrosis.Entities:
Keywords: Cr(VI); Hedgehog pathway; Liver fibrosis; Shh+/−mice
Mesh:
Substances:
Year: 2019 PMID: 31756458 DOI: 10.1016/j.toxlet.2019.11.017
Source DB: PubMed Journal: Toxicol Lett ISSN: 0378-4274 Impact factor: 4.372